Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes

Authors :: Mesher, David
Soldan, Kate
Lehtinen, Matti
Beddows, Simon
Brisson, Marc
Brotherton, Julia M.L.
Chow, Eric P.F.
Cummings, Teresa
Drolet, Melanie
Fairley, Christopher K.
Garland, Suzanne M.
Kahn, Jessica A.
Kavanagh, Kimberley
Markowitz, Lauri
Pollock, Kevin G.
Soderlund-Strand, Anna
Sonnenberg, Pam
Tabrizi, Sepehr N.
Tanton, Clare
Unger, Elizabeth
Thomas, Sara L.
Source :: Emerging Infectious Diseases. October 1, 2016, p1732, 9 p.
Publication Year :: 2016
Abstract: Persistent infection with a high-risk human papillomavirus (HPV) genotype is necessary for development of cervical cancer (1). Two high-risk types, HPV16 and HPV18, cause ≅70%-80% of cervical cancers (2-4). The [...]

Subjects :: Genetic aspects
Health aspects
Genotypes -- Health aspects
Papillomavirus -- Genetic aspects -- Health aspects
Vaccination -- Health aspects
Papillomaviruses -- Genetic aspects -- Health aspects
Genotype -- Health aspects

Full Text Access

Tools